1. Market Research
  2. > Pharmaceutical
  3. > Therapy Market Trends
  4. > Cancer Drug News 01 DECEMBER 2014

Cancer Drug News 01 DECEMBER 2014

  • December 2014
  • -
  • Espicom Business Intelligence
  • -
  • 20 pages

Industry Trend Analysis - CAR-T Therapy Arena Heats Up With Another Biotech Collaboration
Industry Brief - Eisai Launches Halaven In Brazil
Industry Brief - Dr Reddy's Launches Docetaxel Injection In US
Industry Brief - FDA Grants Breakthrough Therapy Designation To Juno's T-Cell Therapy For ALL
Industry Brief - Iclusig Gains Marketing Approval In Australia
Industry Brief - Janssen To Start Daratumumab Phase II Study In SMM
Industry Brief - OBT/Menarini Group Initiate First-In-Human Study Of Enhanced Antibody For AML
Industry Brief - FDA Extends Priority Review Period For Novartis' LBH589
Industry Brief - Health Canada Approves Gazyva For Treatment Naïve CLL Patients
Industry Brief - Nordic Nanovector/Affibody Collaborate On Advanced RIT Programme For MM
Industry Brief - DSMB Recommends Continuation Of CPX-351 Phase III AML Study
Industry Brief - EC Approves BI's Vargatef For NSCLC After First-Line Chemotherapy
Industry Trend Analysis - Second Trial Failure Questions Cabozantinib's Future
Industry Brief - DSMB Recommends Continuation Of Livatag Phase III Trial In HCC
Industry Brief - Concordia Updates On Photofrin Phase III Trial; Signs Distribution Deal With Union Med
Industry Trend Analysis - Five Prime Collaboration To Aid BMS In Anti-PD-1 Race With Merck
Industry Brief - Janssen Submits Yondelis NDA To FDA For Advanced STS
Industry Trend Analysis - EORTC-NCI-AACR 2014 Emphasises Shift Towards Personalised Medicine
Industry Brief - AstraZeneca/Cancer Research UK Collaborate For Screening Of Cancer Medicines
Industry Brief - Bioniche Rebrands As Telesta Therapeutics
Industry Brief - Eisai Opens New Packaging Facility In UK For Cancer Treatment
Industry Brief - COT Raises Funds In Third Tranche Of Private Placement
Industry Brief - AbbVie Acquires API Manufacturing Facility In Singapore; Expands Capabilities In Asia
Industry Brief - CARsgen Closes Series A Financing
Industry Brief - Cancer Conferences - March 2015

Table Of Contents

Cancer Drug News 01 DECEMBER 2014

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
PharmaPoint: Major Depressive Disorder - Global Drug Forecast and Market Assessment to 2025

PharmaPoint: Major Depressive Disorder - Global Drug Forecast and Market Assessment to 2025

  • $ 10995
  • Industry report
  • October 2016
  • by Global Data

PharmaPoint: Major Depressive Disorder - Global Drug Forecast and Market Assessment to 2025 Summary Major depressive disorder (MDD) is one of the most common psychiatric diseases worldwide. It is characterized ...

Colorectal Cancer KOL Insight 2016

Colorectal Cancer KOL Insight 2016

  • $ 8085
  • Industry report
  • October 2016
  • by Firstword Pharma

KOLs embrace novel MoAs as low survival rates drive search for new treatments Faced with persistently low survival rates, KOLs are calling for new approaches to treat late-stage colorectal cancer (CRC). ...

Frontier Pharma: Hepatitis C - Diverse Range of First-in-Class Host-Targeting and Direct-Acting Antivirals Offer Potential in Difficult-to-Treat Populations

Frontier Pharma: Hepatitis C - Diverse Range of First-in-Class Host-Targeting and Direct-Acting Antivirals Offer Potential in Difficult-to-Treat Populations

  • $ 6995
  • Industry report
  • December 2016
  • by GBI Research

Frontier Pharma: Hepatitis C - Diverse Range of First-in-Class Host-Targeting and Direct-Acting Antivirals Offer Potential in Difficult-to-Treat Populations Summary Hepatitis C is a blood-borne viral infection ...


ref:plp2014

Reportlinker.com © Copyright 2017. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.